Sign Up
OverviewAPI
Advancements in blood tests for early-stage ovarian cancer and lung cancer have been made, showcasing the potential for early detection and monitoring of these diseases. Delfi Diagnostics and Nomination Committee have taken key steps in this field, aiming to enhance screening and diagnosis through machine learning and cell-free DNA analysis.

Ask a question